Silvia Buonamici Selected Research

Silvia Buonamici Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 01/2007
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 04/2004
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 05/2002
6	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2009 - 01/2007
5	Leukemia 12/2018 - 08/2003
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2017
3	T-Cell Leukemia (Leukemia, T Cell) 05/2008 - 01/2007
1	Hypersensitivity (Allergy) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Mesothelioma 01/2019
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 12/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2017
1	Philadelphia Chromosome 01/2017
1	Refractory Anemia 12/2016
1	Glioblastoma (Glioblastoma Multiforme) 11/2013
1	Rhabdoid Tumor (Rhabdoid Tumors) 12/2010
1	Glioma (Gliomas) 12/2010
1	Brain Neoplasms (Brain Tumor) 09/2010
1	Medulloblastoma 09/2010
1	Infections 09/2004
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2004
1	Carcinogenesis 08/2003

Drug/Important Bio-Agent (IBA)

7	RNA Splicing FactorsIBA 01/2024 - 01/2016
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2004
2	RNA Precursors (Precursor, mRNA)IBA 12/2018 - 11/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 08/2003
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2013 - 09/2010
2	Ligases (Synthetase)IBA 06/2008 - 08/2007
2	UbiquitinIBA 06/2008 - 08/2007
1	CohesinsIBA 01/2024
1	InterferonsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 12/2018
1	Phosphotransferases (Kinase)IBA 12/2018
1	EnzymesIBA 12/2018
1	venetoclaxIBA 10/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	H3B-8800IBA 01/2018
1	MTOR InhibitorsIBA 01/2018
1	pladienolide BIBA 01/2018
1	H3B-5942IBA 01/2018
1	Fulvestrant (Faslodex)FDA Link 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2017
1	H3B-6527IBA 12/2017
1	palbociclibIBA 12/2017
1	Small Interfering RNA (siRNA)IBA 12/2017
1	asciminibIBA 01/2017
1	RNA Splice SitesIBA 11/2015
1	6-deoxypladienolide DIBA 11/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2013
1	TensinsIBA 11/2013
1	ZincIBA 12/2010
1	Carrier Proteins (Binding Protein)IBA 09/2010
1	Guanosine Triphosphate (GTP)IBA 09/2010
1	Smoothened ReceptorIBA 09/2010
1	sonidegibIBA 09/2010
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 09/2010
1	Chemokine ReceptorsIBA 06/2009
1	Cyclin EIBA 06/2008
1	hexamethylene bisacetamide (HMBA)IBA 05/2008
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2007
1	Notch1 ReceptorIBA 02/2007
1	NF-kappa B (NF-kB)IBA 01/2007
1	Thalidomide (Thalomid)FDA Link 08/2004
1	Arsenic Trioxide (Trisenox)FDA Link 08/2004
1	methylamphotericin B (AME)IBA 08/2003
1	AcetyltransferasesIBA 08/2003
1	CBFbeta-MYH11 fusion proteinIBA 05/2002

Therapy/Procedure

8	Therapeutics 01/2021 - 04/2004
2	Drug Therapy (Chemotherapy) 01/2019 - 06/2009
1	Castration 01/2020
1	Cranial Irradiation 06/2009
1	Transplantation 09/2004